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Obesity in chronic hepatitis C (CHC) is associated with adverse hepatic and metabolic outcomes. This prospective study evaluates
the agreement between self-perceived body weight (BW) status and measured body mass index (BMI) category and factors
associated with its underestimation in CHC. Body size perception was measured with the Contour Drawing Rating Scale.
Two hundred and seventy-three patients with CHC (overweight 45%, obese 18%) participated in this study. Although both
overweight and obese demonstrated good body size perception, agreement between perceived BW and measured BMI categories
was poor (κ = 0.315, 95% CI 0.231–0.399); 33% of overweight/obese respondents considered themselves normal or underweight.
Male gender (OR 2.84) and overweight (OR 2.42) or obese BMI (OR 14.19) were associated with underestimation of BW
category. Targeted interventions are needed to improve body weight perception, thereby enhancing the uptake of health advice
on management of excess body weight in CHC.
1.Introduction
Obesity (body mass index, BMI ≥ 30kg/m2) is a worldwide
health hazard, the prevalence of which has increased steadily
over time. Hepatitis C virus (HCV) chronically infects
170 million worldwide [1]. Untreated, CHC is associated
with signiﬁcant long-term clinical consequences including
cirrhosis, liver failure and hepatocellular cancer (HCC).
Recent observations suggest a mechanistic link between
hepatitis C viremia and the development of obesity. The
prevalence of obesity amongst patients with CHC in a
tertiary referral unit in Canada was reported to be 28.8%,
over double that of the general population [2]. Obesity was
observed signiﬁcantly more often amongst viremic patients
with CHC than in matched patients exposed to hepatitis C
(i.e., HCV antibody positive) but who were not viremic [2].
Furthermore, leptin receptor expression has been observed
to be increased in hepatocyte cell cultures transfected with
the hepatitis C viral core protein [3].
Body weight inﬂuences both the hepatic and metabolic
outcomes in CHC in that obesity in CHC is associated with
nonresponse to antiviral therapy and higher risk of HCC
[4, 5]. Both obesity and CHC are independently associated
with a range of metabolic manifestations including hepatic
steatosis, insulin resistance (IR), and type 2 diabetes [6,
7]. These metabolic complications also impair response
to peginterferon and ribavirin (the standard of care) and
are associated with more rapid progression of liver disease
thereby increasing the risk for the development of cirrhosis
and HCC [8, 9]. Obese individuals who go on to liver
transplantation experience higher rates of posttransplant
diabetes and reduced survival [6, 10].2 Journal of Obesity
Obesity is an important potentially modiﬁable risk
factor, which if identiﬁed and intervened upon may lead
to a reduction in these adverse outcomes in CHC. How-
ever, overweight or obese individuals who do not perceive
themselves to be overweight or obese may fail to seek or
respond to such interventions. Self-perceived weight status
correlatesmorestronglythanactualBMIwithintentionsand
actions to avoid weight gain [11]. Population studies from
the USA and Europe indicate that male gender, age, lower
socioeconomic status, ethnic origin, level of education, and
rural (versus urban) area of residence inﬂuence subjective
weight status [11–14]. To date, body weight perception has
not been studied speciﬁcally in patients with CHC.
Brief intervention administered through pamphlet mail-
out led to increased awareness of healthy weight ranges
and improved eating habits in a population-based cohort
[15]. In the primary care setting, brief low intensity face-to-
face intervention achieves beneﬁts similar to those achieved
by more intensive interventions and pharmacotherapy [16].
Such interventions aimed at improving perception, thereby
promoting a change in behavior, may be helpful in over-
weight and obese patients with CHC who are at high risk
for hepatic and metabolic complications speciﬁcally related
to their infection.
Therefore,theprimaryaimofthisstudywastodetermine
whetheragreementexistsbetweenperceivedbodyweightsta-
tusandmeasuredBMIcategoryinpatientswithchronichep-
atitis C. We hypothesized that BW category underestimation
would occur more often amongst the overweight and obese
as compared to their counterparts with a normal BMI.
We aimed to identify any additional patient characteristics
associated with underestimation of BW category thereby
identifying patient subgroups that may require targeted
education. The secondary aim was to determine whether a
brief educational intervention might improve the accuracy
of body weight perception, as measured via a change in
agreement over time.
2.SubjectsandMethods
This prospective study conforms to the ethical guidelines
of the 1975 Declaration of Helsinki and its amendments
as reﬂected in a priori approval by the Research Ethics
Board of the University Heath Network; informed consent
was obtained from each patient included in the study.
BetweenMarch2009andAugust2009,allpatientswithCHC
attending the liver clinic of Toronto Western Hospital were
eligible for inclusion. Patients with ascites, hepatoma, or
pregnancy were excluded from participation as body weight
is inﬂuenced by these conditions. As the overweight/obese
were the target for intervention, patients who were identiﬁed
as underweight (BMI < 18.5kg/m2) were also excluded.
During the study period, 736 patients with CHC
attended the liver clinic. A convenience sample of 305
patients was approached to participate in the study, of which
22 refused (7.2%). Ten patients were excluded (1 pregnant,
5 ascites and/or hepatoma, 4 underweight). Hence 273 (37%
of hepatitis C clinic attendees) patients initiated the study.
Height in metres (m) to the nearest 0.01m and body
weight (BW) in kilograms (kg) to the nearest 0.1kg are rou-
tinely measured at each clinic visit. Patients were informed
of their measurements and then completed a structured
questionnaire designed for the purposes of the study. Based
on their current weight, participants were asked to classify
themselves as “underweight,” “about the right weight,”
“overweight,” or “very overweight.” Moreover, they were
asked to report their perception of the absolute body weight
(in pounds or kilograms) that they would have to be in order
to be considered “about the right weight,” “overweight,”
or “very overweight (obese).” Thirdly, perception of “self”
and “healthy” body size was performed with the use of
the Contour Drawing Rating Scale (CDRS) [17]. This is a
validated tool consisting of 9 male and 9 female contour
drawings increasing size/body contour marked 1 (thinnest)
to 9 (widest) allowing an ordinal value to be assigned to the
imageselected.Participantswereaskedtoputacrossoverthe
body shape image that they perceived to best represent their
“current body shape,” and a subsequently a “healthy body
shape.” As no deﬁnition for “healthy” exists on this scale, the
ordinal scale was to be used to compare respondents’ relative
perceptions of body size.
Actual BMI was calculated for each patient using the
equation: measured weight (kg) divided by the square of
height (m). Respondents’ were categorised by the World
Health Organization (WHO) deﬁnitions of normal (BMI
18.5–24.9), overweight (BMI 25–29.9), and obese (BMI ≥
30) [18].
Demographic and clinical data collected included age,
gender, ethnicity, years of education, area of residence,
employment status, antiviral treatment status, stage of liver
disease (cirrhotic or noncirrhotic), and presence of any con-
current metabolic diseases (diabetes, hypertension, hyper-
lipidemia, or cardiovascular disease). These characteristics
were selected because they have previously been reported to
be associated with overweight/obesity, hence their inﬂuence
on body weight perception was to be determined.
After completion of the questionnaire, participants were
given immediate feedback by the investigators in the form
of a printed “fact sheet” and face-to-face education adminis-
teredover5–10minutes.Theinterventionwasdesignedboth
for the evidence supporting the utility of brief interventions
[15, 16] and to ensure the feasibility of its administration in
a hepatology clinic. The fact sheet combined both general
and tailored information, as tailoring has been shown to
positivelyinﬂuencehealthbehaviourchangewhencompared
to nontailored methods [19, 20]. This fact sheet outlined
the WHO deﬁnitions of body mass index (BMI) categories
and information speciﬁc to the respondent (the calculated
body weight ranges that would correspond to normal,
overweight, and very overweight (obese) for their height).
The signiﬁcance of body weight in CHC was also explained,
as were recommendations for simple measures to attain or
maintain healthy body weight based on the Health Canada
guidelines [21, 22].
A follow-up questionnaire was mailed to participants
4–6 weeks later (comprising the same questions regarding
perception as the initial questionnaire) to determine howJournal of Obesity 3
perception of body weight changed with the intervention. Of
the 273 patients that initiated the study, 104 (38%) returned
the follow-up questionnaire.
Statistical analyses were performed using SPSS 17.0
(Chicago, USA) and WinBUGS (MRC Biostatistics, Cam-
bridge, UK). The primary outcome for analysis was under-
estimation of BW category. Participants were categorised
as underestimators if their self-perceived BW category was
lower than their measured BMI category. Cohen’s kappa
statistics were computed to measure agreement. Univariate
logistic regression was used to determine variables associated
with underestimation of BW category; factors signiﬁcantly
associated with underestimation of BW category at univari-
ate analysis (i.e., 95% conﬁdence interval not crossing 1.0)
were entered into the multiple logistic regression model.
Collinearity between variables was evaluated using pseudo-
R-square test. The “goodness of ﬁt” of ﬁnal model was
conﬁrmed with the Akaike information criterion (AIC);
the covariates included in the ﬁnal model minimized the
AIC. The results of the postintervention questionnaire were
compared with those at baseline only for those patients who
completed both questionnaires.
3. Results
Table 1 lists the demographic and clinical characteristics of
the 273 patients who completed the baseline questionnaire.
Calculated from weight and height measurements at base-
line, 37% had a normal BMI, 45% were overweight, and 18%
were obese.
3.1. Perception of Body Size. With regard to the respondents’
selectionofbodycontourimageassociatedwiththeircurrent
body size (i.e., “self”), there was a wide range of responses
across each of the BMI categories (Figure 1(a)). Overall,
obeserespondentstendedtoselectimageshigher(i.e.,larger)
on the CDRS than overweight respondents, who in turn
selectedimageshigheronthescalethannormalBMIrespon-
dents. This indicated that respondents had good perceptions
oftheirbodysizerelativetoothers.AcrossallBMIcategories,
respondents most frequently identiﬁed “healthy” body size
with images in the centre of the CDRS (Figure 1(b)),
suggesting that regardless of their current weight status,
respondents had similar perceptions of healthy body size.
3.2. Agreement between Self-Perceived Body Weight Category
and Measured BMI Category (Table 2). There was poor
agreement between respondents’ perceived BW category and
their measured BMI category (κ = 0.315, 95% CI 0.231–
0.399). Only 56% of respondents’ perceived BW categories
corresponded to their measured BMI category. Fifty percent
of overweight and obese respondents underestimated their
BW category, 2/3 of these considering themselves normal
or even underweight. Although the majority of obese
individuals considered themselves to be in a category higher
than “normal”, almost 2/3 of obese did not recognise the
degree of their overweight, categorising themselves as only
overweight rather than very overweight (obese).
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Figure 1: Contour Drawing Rating Scale results. Body shape
perceived to be associated with (a) “self” and (b) “healthy”.
3.3. Body Weights Perceived to Be Associated with Normal,
Overweight, and Very Overweight (Obese). Amongst respon-
dents with normal BMI, the mean BMI calculated from
weights perceived to be associated with normal, overweight,
and very overweight (obese) closely corresponded to BMI
categories as deﬁned by WHO (Table 3). However, amongst
overweight and obese respondents, the weights perceived to
be associated with the BW categories corresponded to higher
BMIs. For example, obese respondents reported weights
perceived to be associated with “very overweight (obese)”
corresponding to a mean BMI of 36 ± 6.4kg/m2, whilst
the corresponding mean BMI for overweight and normal
respondents were 32.9 ± 11.7kg/m2 and 29.4 ± 6.5kg/m2,
respectively. These results indicate that overweight and obese
individuals have poor perceptions of the absolute weights
associated with being overweight and obese and that the
magnitude of the discrepancy is larger for obese compared
to overweight and normal subjects.
3.4. Factors Associated with Underestimation of Body Weight
Category (Table 4). Univariate analysis of the demographic
and clinical characteristics (from Table 1)w a sp e r f o r m e dt o4 Journal of Obesity
Table 1: Demographic and clinical characteristics of patients answering baseline questionnaire.
Characteristic Measured BMI category
Normal
n = 101 (37%)
Overweight
n = 124 (45%)
Obese
n = 48 (18%)
BMI (kg/m2) 22.2 ± 1.9 27.2 ± 1.4 33.6 ± 3.9
Demographic characteristics
Age (years) 51.4 ± 11.8 53.5 ± 10.9 53.0 ± 9.8
Gender (male) 53 (52%) 83 (67%) 30 (62%)
Ethnicity
Caucasian 74 (73%) 88 (72%) 34 (70%)
East/South-East Asian 15 (15%) 7 (6%) 1 (2%)
South Asian 3 (3%) 13 (10%) 6 (13%)
Other 9 (9%) 15 (12%) 7 (15%)
Canadian born 54 (53%) 64 (52%) 31 (65%)
Area of residence (urban) 77 (76%) 87 (70%) 28 (58%)
Years of education 13.1 ± 3.64 12.8 ± 4.0 11.7 ± 3.4
Employment (employed) 51 (51%) 70 (56%) 17 (35%)
Clinical Characteristics
Treatment status
Na¨ ıve 57 (56%) 53 (43%) 17 (35%)
Nonresponder/relapser 27 (27%) 36 (29%) 19 (40%)
SVR 9 (9%) 25 (20%) 8 (17%)
On treatment 3( 3 % ) 5( 4 % ) 3( 6 % )
Spontaneous clearance (untreated) 4( 4 % ) 5( 4 % ) 1( 2 % )
HCV RNA positive 88 (87%) 94 (76%) 39 (81%)
Cirrhosis 31 (31%) 54 (44%) 25 (52%)
Diabetes 6 (6%) 14 (11%) 6 (12%)
Hypertension 16 (16%) 30 (24%) 13 (27%)
Hyperlipidemia 6 (6%) 11 (9%) 5 (10%)
Cardiovascular disease 4( 4 % ) 4( 3 % ) 3( 6 % )
Any metabolic disease 24 (24%) 41 (33%) 19 (40%)
R e s u l t sa r ee x p r e s s e da sm e a n± standard deviation or n (%) where appropriate.
Table 2: Survey responses—measured BMI category versus perceived body weight category.
Measured BMI category
Underweight Normal
n = 101 (37%)
Overweight
n = 123 (45%)
Obese
n = 48 (18%)
Underweight 0 (0%) 21(21%)2 ( 2 %)0 ( 0 %)
Considering your current
weight, About right (normal) 0 (0%) 69 (68%) 47(38%) 7(14.5%)
how would you classify
yourself? Overweight 0 (0%) 11 (11%) 74 (60%) 30(62.5%)
n = 272 Very overweight (obese) 0 (0%) 0 (0%) 0 (0%) 11 (23%)
Cases in bold represent numbers (%) of respondents who underestimated their BMI category. κ = 0.315, 95% CI 0.231–0.399.
identify factors associated with underestimation of BW cat-
egory. Demographic characteristics associated with under-
estimation included male gender, rural area of residence,
fewer years of education, and unemployment. Clinical
factors associated with underestimation included obese or
overweight BMI and a history of diabetes, hypertension, or
“any metabolic disease”.
The ﬁnal multivariate model included the covariates
found to be signiﬁcant at univariate analysis with the
exception of diabetes and hypertension (as hypertensionJournal of Obesity 5
Table 3: Survey responses—corresponding BMI calculated from weights perceived to be associated with body weight categories.
Measured BMI category
Normal
n = 101
Overweight
n = 124
Obese
n = 48
What do you think your weight
should be to be considered about
right (normal)?
22.3 ± 1.8
n = 99
25.11±1.77
n = 123
27.2 ± 2.8
n = 48
BMI (kg/m2)c a l c u l a t e d
from perceived weight
What do you think your weight
would have to be to be
considered overweight?
25.5 ± 2.8
n =96
28.5 ± 4.1
n = 120
30.5 ± 4.3
n = 47
What do you think your weight
would have to be to be considered
very overweight (obese)
29.4 ± 6.5
n = 95
32.9 ± 11.7
n = 120
36.0 ± 6.4
n = 47
R e s u l t sa r ee x p r e s s e da sm e a n± SD and number of respondents (n)f o re a c hi t e m .
and diabetes were subsets of “any metabolic disease”, and
collinearitywith“anymetabolicdisease”wasconﬁrmed)and
area of residence (because of its marginal contribution to the
overall model ﬁt). Multivariate analysis demonstrated that
overweight and obese BMI and male gender were signiﬁ-
cantly associated with underestimation of BW category.
We explored whether the ﬁndings would change if Asian
participants were recategorised using WHO-suggested race-
speciﬁc (i.e., lower) BMI cut-oﬀs for overweight and obese
[23]. An additional 7 Asian respondents would have been
categorised as “underestimators”, thereby further reducing
the agreement between actual BMI category and perceived
BW category. The factors found to be signiﬁcant by uni-
variate and multivariate analysis were unchanged (data not
shown), therefore not aﬀecting the overall observations of
the present study.
3.5. Impact of the Brief Educational Intervention. One hun-
dred and four respondents returned the follow-up question-
naire (38.1%). This follow-up cohort was not signiﬁcantly
diﬀerent in any of the baseline clinical or demographic
characteristics to the cohort who declined to participate in
the follow-up questionnaire.
The rate of underestimation of body weight category
was 38.5% (40/104) preintervention and 41.3% (43/104)
postintervention; when comparing the agreement between
perceived BW category and measured BMI category before
and after the educational intervention, no signiﬁcant change
was observed (κ = 0.366, 95% CI 0.253−0.501 versus 0.309,
95% CI 0.182−0.442). Although the BMIs calculated from
weights perceived to be associated with normal, overweight,
and very overweight (obese) at followup were still discrepant
to the WHO cut-oﬀs, mean BMIs calculated from perceived
weights tended to be lower (i.e., closer to the WHO cut-oﬀs)
suggesting a trend to improvement in BW perception across
thegroupsafterthebriefeducationalintervention(Figure 2).
4. Discussion
Attaining and maintaining healthy body weight is a vital
consideration in the management of patients with CHC.
This study demonstrates that although patients with CHC
Table 4: Logistic regression for predictors of BMI category under-
estimation.
Characteristic Univariate Multivariate
OR (95% CI) OR (95% CI)
BMI
Normal Ref Ref
Overweight 2.57 (1.41−4.69) 2.42 (1.29−4.55)
Obese 12.81 (4.69−29.30) 14.19 (5.71−35.28)
Gender (Male) 2.28 (1.35−3.83) 2.84 (1.52−5.30)
Area of residence
Urban Ref —
Rural 1.77 (1.05−3.01)
Years of education 0.92 (0.86−0.98) 0.94 (0.86−1.01)
Employment
Employed Ref Ref
Unemployed 1.83 (1.12−3.00) 1.59 (0.87−2.89)
Any metabolic disease 2.15 (1.27−3.62) 1.50 (0.82−2.74)
Diabetes 3.23 (1.39−7.56) —
Hypertension 1.8 (1.01−3.23) —
CI: conﬁdence interval.
have good perception of their body size in relation to a
“healthy” body size, one third perceived that they were
normalorunderweight.Themajorityofobesethatrecognise
their excess body weight do not recognise their degree of
overweight. Overweight and obese had poor perceptions of
the absolute body weights associated with normal, over-
weight,andobeseasdemonstratedbythehigherBMIscalcu-
lated from the perceived weights. By obtaining quantitative
measures of perception of body weight with regard to BW
category, we have demonstrated that the overweight/obese
with CHC do not appreciate when substantial excess body
weight is already present. Although studies have examined
body weight perception in the general population, diabetics,
children and adolescents, and in cohorts with eating dis-
orders, no studies prior to ours have studied body weight
perception in CHC. In view of the important adverse hepatic
and metabolic sequelae of obesity in the setting of CHC, the
ﬁndings of this study need to be addressed.6 Journal of Obesity
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educational intervention.
An important aspect of our study design was the actual
measurement of weight and height at the time of question-
naire, rather than relying on self-reported weight and height
as done by some population studies examining this ﬁeld
[11, 12]. Self-reported weight and height may themselves
be subject to mis-perception and hence be inaccurate,
potentially biasing the ﬁndings of obesity studies [24–26].
Being overweight or obese was independently associated
with underestimation of BW category implying that poor
perception or awareness of appropriate body weight likely
contributes to behaviours that directly lead to an individ-
ual’s body weight excess. There is clear evidence that the
prevalence of overweight/obesity continues to increase, and
overweight and obese individuals now comprise the over-
whelming majority worldwide [18]. The “obesity epidemic”
may in itself contribute to the misperceptions, as overweight
and obese individuals are surrounded by more people of like
body habitus, thereby shifting their frames of reference as to
whatis“normal.”Thishasbeendemonstratedinschool-aged
children and adolescents [27] and may explain why some
respondentsinourpopulationdidnotrecognisethepresence
and/or degree of overweight/obesity. In our population with
CHC, raising the awareness or improving the perception of
an individuals’ body weight has the potential to improve
patients’ adherence to weight management strategies and
lead to long-term improvements in liver and non-liver
related health outcomes.
A Cochrane systematic review concluded that the over-
weight and obese beneﬁt from psychological interventions
to enhance weight reduction achieved through combined
dietary and exercise strategies [28]. Numerous studies exam-
ine the eﬀect of educational and psychological interventions
on behaviour change aimed towards weight loss; however
interventions focused on the misperceptions regarding body
weight which may underlie an individual’s behavior also
need to be considered. Brief cognitive-behavioural inter-
ventions improve body image misperceptions in women
with high levels of body shape concern [29]. Similar
principles may be needed to shift misperceptions amongst
the overweight and obese with CHC who underappreciate
the signiﬁcance of their body weight. Self-perceived weight
status most strongly correlates with intentions and actions
to avoid weight gain [11], therefore the misperceptions of
body weight need to be addressed before an individual will
institute such a change in behaviour. Improving perception
may allow an individual to progress through the ﬁrst
stages of the transtheoretical theory of behaviour change:
precontemplation, contemplation, preparation, and action
[30].
In this initial exploratory study of the perception of body
weight amongst patients with CHC, a control group was
not recruited; rather, the obese and overweight with CHC
have been compared with their normal BMI counterparts.
Patientswithotherliverconditionswhoattendtheliverclinic
(e.g., nonalcoholic fatty liver disease, hepatitis B and autoim-
mune liver disease) have markedly diﬀerent characteristics to
patients with CHC, hence they are unsuitable comparators
[31–33]. Within the local community, the recruitment of
a “healthy” control group of suitable sample size matched
for BMI, age, gender, ethnicity, education, and metabolic
comorbidity was also considered unfeasible. Therefore, the
observations made in the present study stand alone as the
ﬁrst report of body weight perception in CHC. Despite
this potential limitation, our ﬁndings may be interpreted in
comparison to studies concerning body weight perception in
diabetics and in larger population-based cohorts.
In line with the ﬁndings of large US population studies
[13, 14], we demonstrated that males are more likely to
underestimate their BW category and therefore are at risk
of underestimating their health and liver-related risk. It has
been postulated that males may be less likely to recognise
their own overweight/obesity than women because, at the
same BMI, males have a higher muscle:fat ratio [13]. This
gender diﬀerence in body weight perception in our popu-
lation is particularly important as male gender independent
of body weight is associated with more rapid progression of
liver disease in CHC [34], hence overweight/obese men are
at high risk of the complications of overweight/obesity and
CHC. Future-targeted education programs should recognise
the impact of gender on the accuracy of weight self-
perception. In contrast to large population studies, we did
not demonstrate any association between misperception of
BW category and age, socioeconomic status, ethnic origin,
level of education, or area of residence; this may have been
the result of the limited sample size of the present study.
Despite a relatively short period of time between
the intervention and the followup (4−6 weeks), and the
combination of tailored printed material and face-to-face
education, the brief intervention failed to yield signiﬁcant
improvements in BW perception; these ﬁndings highlight
the stability of the body weight misperceptions in thisJournal of Obesity 7
cohort of patients with CHC. Opportunistic reinforcement
at future consultations should be attempted; however, more
structured and focused counseling and education may
be warranted. Interventions may include advice on habit
formation [35], the provision of more detailed general and
tailored printed matter [20], group educational sessions,
and follow-up sessions speciﬁcally for the management of
overweight/obesity in CHC.
Although body composition (% body fat relative to lean
body mass) could be considered to potentially inﬂuence self-
perceptions of body weight, anthropometric measures of
body fat (such as bioelectrical impedance, total body water,
or skinfolds) were not included in the design of the present
study. The BMI cut-oﬀ value for the diagnosis of obesity has
a high speciﬁcity, but low sensitivity to identify adiposity
[36]. Adipose tissue-derived mediators are likely to play a
role in the pathophysiology of the adverse outcomes in CHC;
howeverbodymassindexwasdeliberatelyselectedasthepri-
mary outcome measure because of the reported association
between elevated BMI and aforementioned adverse hepatic
and metabolic outcomes in numerous clinical studies of
CHC [2, 4–10, 37]. As no clear associations have been made
between body fat mass and outcomes in CHC, achieving a
normal BMI (in part through improved perceptions of body
weight) remains a goal in the management of excess body
weight in CHC. Furthermore, utilizing the WHO BMI cut-
oﬀs for BMI categories allowed us to provide clear tailored
health advice to the participants rather than measures of
body adiposity for which there are currently no studies
reporting cut-oﬀ levels associated with improved or poor
outcomes in CHC. The latter is a potential area for further
study.
5. Conclusion
Body weight category underestimation is common in
patients with CHC. Longitudinal studies will be required
to determine which strategies will change perception and
behaviourtowards weightloss and weight maintenance, with
the long-term goal of reducing the metabolic and hepatic
morbidity and mortality associated with excess body weight
in CHC.
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